Myriad Genetics Inc
DUS:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
Vision Marine Technologies Inc
NASDAQ:VMAR
|
CA |
|
CY4GATE SpA
MIL:CY4
|
IT |
|
F
|
Forus SA
SGO:FORUS
|
CL |
|
A
|
Activision Blizzard Inc
LSE:0H8X
|
US |
|
P
|
Paladin Energy Ltd
SWB:PUR
|
AU |
|
Bushveld Minerals Ltd
LSE:BMN
|
ZA |
|
C
|
China Petroleum & Chemical Corp
F:CHUA
|
CN |
|
AltaGas Ltd
TSX:ALA
|
CA |
|
Magnetic Resources NL
ASX:MAU
|
AU |
|
M
|
Medco Energi Internasional Tbk PT
XMUN:MEF
|
ID |
|
T
|
Tegna Inc
XBER:GTT
|
US |
|
Liberty Media Corp
OTC:LLYVB
|
US |
|
Astra International Tbk PT
OTC:PTAIF
|
ID |
|
Energous Corp
NASDAQ:WATT
|
US |
|
N
|
Nano Nuclear Energy Inc
NASDAQ:NNE
|
US |
|
Lovisa Holdings Ltd
F:LO7
|
AU |
|
Coty Inc
NYSE:COTY
|
US |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
529.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
458.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.3m USD. This includes both short-term (0 USD) and long-term (120.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
